Company
The Great Pioneer for Incurable Diseasest
리스큐어바이오사이언시스는 글로벌 임상단계의 혁신신약 연구개발 전문기업으로 미생물 기반 면역항암 주사제와 경구형 마이크로바이옴 치료제를 개발하고 있습니다.
Leadership
Team
-
CEO진화섭Bio Industry 20+ yrs
-
COO심재석, Ph.D.Material development,
Industrialization 20+ yrs -
CTO노성운, Ph.D.Microbiome research 20+ yrs
-
CTO송경섭, Ph.D.Metabolism research 14+ yrs
-
CFO김태희Pharmaceutical Bio Analysts, 17+yrs
-
상무안지영Clinical Development, 20+yrs
Scientific Advisory Board
-
SABTheresa LaVallee, Ph.D.Pre-clinical, clinical 25+ yrs
-
SABRobert R. Jenq, M.D.Cancer immunology 20+ yrs
-
SABNicholas F. LaRusso, M.D.Liver disease 35+ yrs
R&D Advisory
-
David J. Pepperl, Ph.D.Pre-clinical, IND 20+ yrs
-
남기연, Ph.D.Clinical development 20+ yrs
Co-Researchers
-
Harmeet Malhi, M.B.B.S.Mayo Clinic,
Liver disease 20+ yrs -
Howard C. Hang, Ph. D.Scripps Research Institute,
Bacteria Immunology 20+ yrs